SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-20-275551
Filing Date
2020-10-23
Accepted
2020-10-23 16:48:31
Documents
8

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ON FORM S-3 d32033ds3.htm S-3 405076
2 EX-1.2 d32033dex12.htm EX-1.2 211740
3 EX-4.4 d32033dex44.htm EX-4.4 300268
4 EX-5.1 d32033dex51.htm EX-5.1 27693
5 EX-23.1 d32033dex231.htm EX-23.1 1410
6 GRAPHIC g32033g35e36.jpg GRAPHIC 10410
7 GRAPHIC g32033g48i09.jpg GRAPHIC 44814
8 GRAPHIC g32033g63y49.jpg GRAPHIC 2456
  Complete submission text file 0001193125-20-275551.txt   1021691
Mailing Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080
Business Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080 415-505-0809
Satsuma Pharmaceuticals, Inc. (Filer) CIK: 0001692830 (see all company filings)

IRS No.: 813039831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-249645 | Film No.: 201258215
SIC: 2834 Pharmaceutical Preparations